3D Bio Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8.46M
Latest Deal Amount
  • Investors
  • 3

3D Bio Therapeutics General Information

Description

Developer of 3D-bioprinting and materials technologies designed to treat disease and congenital medical conditions. The company's technologies focus on regenerative medicine that precision manufactures living tissues to help the replacement of each individual patient's parts with tissues designed and created specifically for them, enabling doctors to have capabilities that permit the creation of living tissue implants for therapeutic applications.

Contact Information

Website
www.3dbiocorp.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • 430 East 29th Street
  • 14th Floor
  • New York, NY 10282
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

3D Bio Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 10-Apr-2019 $8.46M 00.000 000.00 Completed Pre-Clinical Trials
To view 3D Bio Therapeutics’s complete valuation and funding history, request access »

3D Bio Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view 3D Bio Therapeutics’s complete cap table history, request access »

3D Bio Therapeutics Executive Team (8)

Name Title Board Seat Contact Info
Hod Lipson Ph.D Co-Founder
James Masters Co-Founder
Larry Bonassar Ph.D Co-Founder
Daniel Cohen Ph.D Co-Founder, Chief Executive Officer and Board Member
Nathaniel Bachrach Ph.D Chief Scientific Officer & Executive Vice President
You’re viewing 5 of 8 executive team members. Get the full list »

3D Bio Therapeutics Board Members (6)

Name Representing Role Since
Harlan Weisman MD Self Executive Chairman 000 0000
Kevin Slawin MD Self Board Member 000 0000
Matthew Fitzpatrick 3D Bio Therapeutics Board Member 000 0000
Michael Bator Self Board Member 000 0000
Scott Dylla Ph.D Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

3D Bio Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

3D Bio Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Blue Collective PE/Buyout Minority 000 0000 000000 0
Hibiscus Capital Management Corporate Venture Capital Minority 000 0000 000000 0
Kairos Ventures Venture Capital Minority 000 0000 000000 0
To view 3D Bio Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial